The FDA weighs in on the safety of drug-coated stents. Thom Gunderson, Piper Jaffray Medical Technology Analyst; Dhulsini De Zoysa, Cowen & Co. Managing Director; and CNBC's Sue Herera discuss the stent debate.
Topics:
Politics and Government | Stock MarketInsurance
Sectors:
| Health Care
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT